Effect of vedolizumab combined with mesalazine on patients with ulcerative colitis and its impact on intestinal mucosal barrier function and immune function

Pan Chunsheng; Wang Wei; Wang Keju

doi:10.3760/j.issn.1673-4777.2021.12.018

Home>Articles>Effect of vedolizumab combined with mesalazine on patients with ulcerative colitis and its impact on intestinal mucosal barrier function and immune function

DOI: 10.3760/j.issn.1673-4777.2021.12.018

Effect of vedolizumab combined with mesalazine on patients with ulcerative colitis and its impact on intestinal mucosal barrier function and immune function

Pan Chunsheng

Wang Wei

Wang Keju

Machine-generated Keywords：

Publication Date：2021-12-08

Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)

Pages：4( 1837-1840 )

China Medicine

ISTIC

ISSN：1673-4777

Year, Vol.(Issue)：2021,16(12)